CIAO2B

gene
On this page

Also known as CGI-128MIP18CIA2B

Summary

CIAO2B (cytosolic iron-sulfur assembly component 2B, HGNC:24261) is a protein-coding gene on chromosome 16q22.1, encoding Cytosolic iron-sulfur assembly component 2B (Q9Y3D0). Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. It is a common-essential gene (DepMap: required in 97.4% of cancer cell lines).

Involved in chromosome segregation and protein maturation. Located in cytosol; nucleoplasm; and spindle. Part of MMXD complex and cytosolic [4Fe-4S] assembly targeting complex.

Source: NCBI Gene 51647 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 35 total
  • Druggable target: yes
  • Cancer dependency (DepMap): dependent in 97.4% of screened cell lines (common-essential)
  • MANE Select transcript: NM_016062

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24261
Approved symbolCIAO2B
Namecytosolic iron-sulfur assembly component 2B
Location16q22.1
Locus typegene with protein product
StatusApproved
AliasesCGI-128, MIP18, CIA2B
Ensembl geneENSG00000166595
Ensembl biotypeprotein_coding
OMIM614778
Entrez51647

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000422424, ENST00000562362, ENST00000563490, ENST00000567511, ENST00000568572, ENST00000569299

RefSeq mRNA: 1 — MANE Select: NM_016062 NM_016062

CCDS: CCDS45506

Canonical transcript exons

ENST00000422424 — 5 exons

ExonStartEnd
ENSE000016214416693398766934066
ENSE000016653916693206566932300
ENSE000016875556693422366934402
ENSE000034796776693278066932825
ENSE000036475566693361466933739

Expression profiles

Bgee: expression breadth ubiquitous, 285 present calls, max score 99.07.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 83.4264 / max 229.1838, expressed in 1827 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
15773380.74921826
1577341.90121341
1577320.7761390

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583499.07gold quality
gastrocnemiusUBERON:000138898.77gold quality
hindlimb stylopod muscleUBERON:000425298.63gold quality
C1 segment of cervical spinal cordUBERON:000646998.58gold quality
adenohypophysisUBERON:000219698.42gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451198.36gold quality
spinal cordUBERON:000224098.29gold quality
mucosa of transverse colonUBERON:000499198.25gold quality
muscle of legUBERON:000138398.18gold quality
heart left ventricleUBERON:000208498.15gold quality
apex of heartUBERON:000209898.13gold quality
cardiac ventricleUBERON:000208298.10gold quality
pituitary glandUBERON:000000798.06gold quality
left adrenal gland cortexUBERON:003582598.06gold quality
left adrenal glandUBERON:000123498.02gold quality
right atrium auricular regionUBERON:000663198.00gold quality
right adrenal glandUBERON:000123397.94gold quality
esophagus mucosaUBERON:000246997.90gold quality
prefrontal cortexUBERON:000045197.89gold quality
anterior cingulate cortexUBERON:000983597.87gold quality
amygdalaUBERON:000187697.86gold quality
oocyteCL:000002397.85gold quality
muscle organUBERON:000163097.85gold quality
caudate nucleusUBERON:000187397.84gold quality
cingulate cortexUBERON:000302797.84gold quality
adrenal cortexUBERON:000123597.83gold quality
right adrenal gland cortexUBERON:003582797.83gold quality
nucleus accumbensUBERON:000188297.76gold quality
ganglionic eminenceUBERON:000402397.75gold quality
left coronary arteryUBERON:000162697.73gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-ANND-3yes14.42
E-MTAB-8142yes10.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

16 targeting CIAO2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548P99.9872.253784
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-570-3P99.9672.414910
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-806299.8868.43995
HSA-MIR-556-3P99.7468.751203
HSA-MIR-442799.3470.331854
HSA-MIR-520E-5P99.2768.901513
HSA-MIR-10399-5P99.1769.872610
HSA-MIR-6504-3P99.1769.312891
HSA-MIR-428998.2666.90810
HSA-MIR-447195.1166.84755
HSA-MIR-805995.1166.30646
HSA-MIR-476593.1166.17737

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 97.4% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 9)

  • these findings suggest that FAM96B acts as a regulator of E2-2 through the control of its protein expression. (PMID:21722264)
  • The mammalian proteins MMS19, MIP18, and ANT2 are involved in cytoplasmic iron-sulfur cluster protein assembly. (PMID:23150669)
  • CIA2B-CIA1-MMS19 and CIA2A-CIA1 assist different branches of Fe/S protein assembly and intimately link this process to cellular iron regulation via IRP1 Fe/S cluster maturation and IRP2 stabilization. (PMID:23891004)
  • Co-localization experiments by fluorescent confocal microscopy revealed that FAM96B colocalized with prelamin A in HEK-293 cells. (PMID:24041693)
  • Data suggest that CIA2B and MMS19 physically interact with C-terminus of viperin/RSAD2; CIAO1 appears to function as primary viperin-interacting protein; CIA2A binds to N-terminus of viperin in CIAO1-, CIA2B-, and MMS19-independent fashion. (CIA2B = metallochaperone CIA2B/FAM96B; MMS19 = transcription factor MMS19; CIAO1 = cytosolic iron-sulfur assembly component 1; CIA2A = metallochaperone CIA2A/Fam96a) (PMID:28615450)
  • We performed a yeast two-hybrid screen on a human fetal brain cDNA library and identified FAM96B as a novel binding partner of SelW. FRET analyses confirmed the interaction between SelW’ and FAM96B. (PMID:30876693)
  • FAM96B inhibits the senescence of dental pulp stem cells. (PMID:32039527)
  • Structural insights into Fe-S protein biogenesis by the CIA targeting complex. (PMID:32632277)
  • Fam96b recruits brain-type creatine kinase to fuel mitotic spindle formation. (PMID:36503010)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriociao2bENSDARG00000052010
mus_musculusCiao2bENSMUSG00000031879
rattus_norvegicusCiao2bENSRNOG00000011865
drosophila_melanogastergalla-2FBGN0036107
caenorhabditis_elegansWBGENE00009736

Paralogs (1): CIAO2A (ENSG00000166797)

Protein

Protein identifiers

Cytosolic iron-sulfur assembly component 2BQ9Y3D0 (reviewed: Q9Y3D0)

Alternative names: MSS19-interacting protein of 18 kDa, Mitotic spindle-associated MMXD complex subunit MIP18, Protein FAM96B

All UniProt accessions (4): Q9Y3D0, H3BNV7, J3KS95, J3QLT9

UniProt curated annotations — full annotation on UniProt →

Function. Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. As a CIA complex component and in collaboration with CIAO1 and MMS19, binds to and facilitates the assembly of most cytosolic-nuclear Fe/S proteins. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation, probably by facilitating iron-sulfur cluster assembly into ERCC2/XPD. Together with MMS19, facilitates the transfer of Fe-S clusters to the motor protein KIF4A, which ensures proper localization of KIF4A to mitotic machinery components to promote the progression of mitosis.

Subunit / interactions. Component of the CIA complex. Component of the MMXD complex, which includes CIAO1, ERCC2, CIAO2B, MMS19 and SLC25A5. Interacts with CIAO1, ERCC2 and MMS19; the interactions are direct. Interacts with KIF4A; the interaction facilitates the transfer of Fe-S clusters to KIF4A to ensure proper localization of KIF4A to the mitotic machinery. Interacts with CCDC117; the interaction is direct.

Subcellular location. Nucleus. Cytoplasm. Cytoskeleton. Spindle. Midbody.

Similarity. Belongs to the MIP18 family.

RefSeq proteins (1): NP_057146* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002744MIP18-likeDomain
IPR034904FSCA_dom_sfHomologous_superfamily
IPR039796MIP18Family

Pfam: PF01883

UniProt features (2 total): initiator methionine 1, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y3D0-F185.560.49

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-2564830Cytosolic iron-sulfur cluster assembly

MSigDB gene sets: 99 (showing top): chr16q22, GOBP_PROTEIN_MATURATION, IRF1_Q6, ELK1_01, MCCLUNG_COCAIN_REWARD_4WK, GOCC_SPINDLE, GOCC_MIDBODY, GOBP_CELL_CYCLE_PROCESS, SCGGAAGY_ELK1_02, MULLIGHAN_MLL_SIGNATURE_1_UP, MGGAAGTG_GABP_B, IRITANI_MAD1_TARGETS_UP, GOBP_CHROMOSOME_SEGREGATION, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17, FORTSCHEGGER_PHF8_TARGETS_DN

GO Biological Process (2): chromosome segregation (GO:0007059), protein maturation (GO:0051604)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (9): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), spindle (GO:0005819), cytosol (GO:0005829), midbody (GO:0030496), MMXD complex (GO:0071817), cytosolic [4Fe-4S] assembly targeting complex (GO:0097361), cytoskeleton (GO:0005856)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Metabolism1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
intracellular membraneless organelle2
cell cycle process1
gene expression1
protein metabolic process1
binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1
microtubule cytoskeleton1
cytoplasm1
spindle1
protein-containing complex1
intracellular protein-containing complex1
iron-sulfur cluster assembly complex1

Protein interactions and networks

STRING

1232 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CIAO2BCIAO1O76071998
CIAO2BMMS19Q96T76997
CIAO2BSLC25A5P05141947
CIAO2BSLC25A6P12236945
CIAO2BCIAO3Q9H6Q4878
CIAO2BNUBP1P53384815
CIAO2BCIAPIN1Q6FI81718
CIAO2BERCC2P18074665
CIAO2BRTEL1Q9NZ71655
CIAO2BBRIP1Q9BX63647
CIAO2BNDOR1Q9UHB4642
CIAO2BDNA2P51530622
CIAO2BABCB7O75027556
CIAO2BGLRX3O76003527
CIAO2BNFS1Q9Y697519

IntAct

151 interactions, top by confidence:

ABTypeScore
CIAO2BCIAO1psi-mi:“MI:0915”(physical association)0.950
CIAO1CIAO2Bpsi-mi:“MI:0915”(physical association)0.950
CIAO2BCIAO1psi-mi:“MI:0914”(association)0.950
CIAO2BCIAO1psi-mi:“MI:0407”(direct interaction)0.950
MMS19CIAO1psi-mi:“MI:0914”(association)0.910
MMS19CIAO1psi-mi:“MI:0915”(physical association)0.910
MMS19CIAO2Bpsi-mi:“MI:0915”(physical association)0.830
CIAO2BMMS19psi-mi:“MI:0915”(physical association)0.830
MMS19CIAO2Bpsi-mi:“MI:0407”(direct interaction)0.830
MMS19ERCC2psi-mi:“MI:0915”(physical association)0.690

BioGRID (175): FAM96B (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-Western), FAM96B (Affinity Capture-Western), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid), FAM96B (Co-fractionation), CIAO1 (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid)

ESM2 similar proteins: A0A096MJN4, A8MR89, B3MRT7, B3NYF7, B4H303, B4IMF6, B4JWR9, B4M375, B4NE93, B4PZ52, B4R3T1, B5DKJ8, O01479, O13718, O43236, O62252, P08761, P15807, P16393, P23337, P28661, P32783, P32860, P38829, P40487, P46580, P53893, Q3T0U7, Q54QK1, Q5R6R7, Q6BYP7, Q6CKE9, Q6CLC9, Q6CPN1, Q6FMP0, Q6FTG1, Q75AZ9, Q8RXN5, Q8SY96, Q92599

Diamond homologs: A8MR89, O62252, P38829, Q3T0U7, Q54QK1, Q9C9G6, Q9D187, Q9DCL2, Q9GPR0, Q9H5X1, Q9SR25, Q9UTL0, Q9V968, Q9VTC4, Q9Y3D0

SIGNOR signaling

1 interactions.

AEffectBMechanism
CIAO2B“form complex”“CIAO2B cytosolic iron-sulfur protein assembly complex”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 84 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Cytosolic iron-sulfur cluster assembly574.6×1e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

35 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance27
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

427 predictions. Top by Δscore:

VariantEffectΔscore
16:66932299:CA:Cacceptor_gain0.9900
16:66932301:C:CCacceptor_gain0.9900
16:66933609:CTGA:Cdonor_loss0.9900
16:66933610:TGAC:Tdonor_loss0.9900
16:66933611:GAC:Gdonor_loss0.9900
16:66933612:A:Tdonor_loss0.9900
16:66933613:C:CAdonor_loss0.9900
16:66933646:TG:Tdonor_gain0.9900
16:66933737:AACC:Aacceptor_loss0.9900
16:66933739:CCTGG:Cacceptor_loss0.9900
16:66933740:C:CGacceptor_loss0.9900
16:66933746:G:Cacceptor_gain0.9900
16:66932299:CACT:Cacceptor_loss0.9800
16:66932300:ACTAG:Aacceptor_loss0.9800
16:66932301:C:Aacceptor_loss0.9800
16:66932317:G:Cacceptor_gain0.9800
16:66932779:CCTG:Cdonor_gain0.9800
16:66932825:TC:Tacceptor_loss0.9800
16:66932826:C:CCacceptor_gain0.9800
16:66932827:T:Gacceptor_loss0.9800
16:66933744:T:Cacceptor_gain0.9800
16:66933744:T:TCacceptor_gain0.9800
16:66934264:T:TAdonor_gain0.9800
16:66934267:T:TAdonor_gain0.9800
16:66932297:TTCA:Tacceptor_gain0.9700
16:66932298:TCA:Tacceptor_gain0.9700
16:66932299:CAC:Cacceptor_gain0.9700
16:66932317:G:GCacceptor_gain0.9700
16:66932774:ACTT:Adonor_loss0.9700
16:66932776:TTACC:Tdonor_loss0.9700

AlphaMissense

1057 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:66932261:G:TA145D1.000
16:66932264:G:TA144D1.000
16:66932268:C:GA143P1.000
16:66932273:C:GR141P1.000
16:66932276:T:AE140V1.000
16:66932277:C:TE140K1.000
16:66932278:C:AK139N1.000
16:66932278:C:GK139N1.000
16:66932281:A:CD138E1.000
16:66932281:A:TD138E1.000
16:66932282:T:AD138V1.000
16:66932283:C:GD138H1.000
16:66932288:A:GL136P1.000
16:66932288:A:TL136H1.000
16:66933642:A:GL107P1.000
16:66933660:A:GL101P1.000
16:66933663:C:AG100V1.000
16:66933663:C:TG100D1.000
16:66933664:C:GG100R1.000
16:66933666:A:TI99N1.000
16:66933683:G:CC93W1.000
16:66933684:C:AC93F1.000
16:66933684:C:TC93Y1.000
16:66933685:A:GC93R1.000
16:66933699:G:TP88Q1.000
16:66933700:G:AP88S1.000
16:66933705:A:GF86S1.000
16:66934015:A:GL65S1.000
16:66934024:A:TL62Q1.000
16:66934035:A:CH58Q1.000

dbSNP variants (sampled 300 via entrez): RS1000406021 (16:66935881 C>CTCCTAGAA), RS1000967376 (16:66933369 A>C), RS1002764377 (16:66932782 G>A,C), RS1002905238 (16:66934168 T>C), RS1003225189 (16:66932478 C>T), RS1003292966 (16:66935607 G>A,C,T), RS1005153402 (16:66934966 C>T), RS1005358757 (16:66932004 TC>T,TCC,TCCC), RS1006456135 (16:66931734 T>A), RS1006618489 (16:66932327 G>A,C,T), RS1006669721 (16:66932069 T>C), RS1007251442 (16:66933345 G>C), RS1007609862 (16:66933078 C>T), RS1008958168 (16:66933928 G>A), RS1011410420 (16:66932446 A>C)

Disease associations

OMIM: gene MIM:614778 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4295989 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs11075646CES2, CIAO2B0.000

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression3
sodium arseniteincreases expression, increases abundance2
Rotenonedecreases expression, increases expression2
aristolochic acid Iincreases expression1
triphenyl phosphateaffects expression1
sodium arsenatedecreases expression1
arseniteincreases reaction, affects binding1
cobaltous chloridedecreases expression1
pyrimidifenincreases expression1
ICG 001increases expression1
abrinedecreases expression1
Sunitinibincreases expression1
Arsenicincreases abundance, increases expression1
Doxorubicinincreases expression1
Ivermectindecreases expression1
Smokedecreases expression1
Vitamin Eincreases expression1
Aflatoxin B1increases expression1
Cadmium Chlorideincreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4118721BindingBinding affinity to FAM96B in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assayStudies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — Bioorg Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.